I. Kaneko

发表

6-Ethyl-N,N'-bis(3-hydroxyphenyl)[1,3,5]triazine-2,4-diamine (RS-0466) enhances the protective effect of brain-derived neurotrophic factor on amyloid beta-induced cytotoxicity in cortical neurones.

T. Kubo, Satoko Nishimura, Takako Murasugi, 2003, Pharmacology & toxicology.

In vivo conversion of racemized β‐amyloid ([D‐Ser26]Aβ1–40) to truncated and toxic fragments ([D‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

T. Kubo, Satoko Nishimura, I. Kaneko, 2002 .

Two Japanese Kindreds of Familial Hypercholesterolemia Including Homozygous Cases. A Report of Cases, and Studies on Serum-Lipoproteins and Enzymes

Y. Kitano, I. Kaneko, A. Endo, 1978 .

RS-4252 inhibits amyloid beta-induced cytotoxicity in HeLa cells.

T. Kubo, Satoko Nishimura, Takako Murasugi, 2003, Pharmacology & toxicology.

A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro.

T. Kubo, Satoko Nishimura, Takako Murasugi, 2002, European journal of pharmacology.

A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.

Satoko Nishimura, Takako Murasugi, I. Kaneko, 2002, British journal of pharmacology.

Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.

T. Kubo, I. Kaneko, K. Morimoto, 2001, Neuroscience.

Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser Residue

I. Kaneko, N. Yamada, Yuko Sakuraba, 1995, Journal of neurochemistry.

Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons

K. Yoshimi, I. Kaneko, T. Oda, 1998, Neuroscience.

β‐Amyloid Racemized at the Ser26 Residue in the Brains of Patients with Alzheimer Disease: Implications in the Pathogenesis of Alzheimer Disease

Isao Kaneko, T. Kubo, I. Kaneko, 2003, Journal of neuropathology and experimental neurology.

Drastic neuronal loss in vivo by β-amyloid racemized at Ser26 residue: conversion of non-toxic [D-Ser26]β-amyloid 1–40 to toxic and proteinase-resistant fragments

T. Kubo, I. Kaneko, I Kaneko, 2001, Neuroscience.

A novel β‐sheet breaker, RS‐0406, reverses amyloid β‐induced cytotoxicity and impairment of long‐term potentiation in vitro

Satoko Nishimura, Takako Murasugi, I. Kaneko, 2002 .

In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.

T. Kubo, Satoko Nishimura, I. Kaneko, 2002, Journal of neuroscience research.

Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.

K. Yoshimi, I. Kaneko, T. Oda, 1998, Neuroscience.